The SAM filing argues that CMS, under the direction of Administrator Dr. Mehmet Oz, has bypassed the Administrative Procedure Act (APA) and violated the Federal Food, Drug, and Cosmetic Act (FDCA) by ...
"The MMJ companies will be one of a very few federally legal DEA, FDA approved companies, vertically integrated, with the infrastructure to support pharmaceutical development of botanical drugs at its ...
While Kovler's assessment highlights systemic barriers, MMJ International Holdings is sidestepping the debate entirely. Under CEO Duane Boise, the company has embraced a pharmaceutical model focused ...
"As CMS Prepares to Launch the First Federal Cannabinoid Reimbursement Program, Industry Leaders Warn of a Dangerous Shift ...
Eliminating a THC cap is expected to boost enrollment in the Georgia medical cannabis program and, eventually, trigger a ...
Terrance Cole, the nominee for Administrator of the U.S. Drug Enforcement Administration (DEA), stands at a pivotal juncture with the opportunity to address longstanding issues related to the agency's ...
"The CMS pilot program could establish a federally supported cannabinoid treatment category before FDA botanical drug ...
A Cleveland-founded digital provider of services related to securing and renewing medical marijuana cards has launched in a handful of markets, with plans to enter more. MMJ.com announced itself on ...
Why is there an adversarial relationship between some medical marijuana backers and the Colorado Department of Public Health and Environment? An incident this morning demonstrates why. Because the ...
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. After a pivotal 2020, cannabis legal sales ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results